- Home
- Automated
- List of product information
- INDIGO CARMINE INJECTION 20 MG/5 ML [SIN11374P]
INDIGO CARMINE INJECTION 20 MG/5 ML [SIN11374P]
Active ingredients: INDIGO CARMINE INJECTION 20 MG/5 ML
Product Info
INDIGO CARMINE INJECTION 20 MG/5 ML
[SIN11374P]
Product information
Active Ingredient and Strength | INDIGO CARMINE - 4 MG/ML |
Dosage Form | INJECTION |
Manufacturer and Country | HOSPIRA AUSTRALIA PTY LTD - AUSTRALIA |
Registration Number | SIN11374P |
Licence Holder | PHEBRA (SE ASIA) PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | V04CH02 |
Indications
Indigo Carmine Injection is used to localise ureteral orifices during cystoscopy and ureteral catheterisation, and as a marker to identify severed ureters and fistulous communications.
Dosage and Administration
Indigo Carmine Injection should be administered by intravenous injection. The recommended amount of indigo carmine to be administered to adults is 20 to 40 mg. Indigo carmine should appear in the bladder within 10 to 15 minutes.
Contraindications
Indigo Carmine Injection is contraindicated in patients who have known hypersensitivity to the drug or synthetic dyes.
